Cargando…

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction

AIMS: Heart failure with preserved ejection fraction (HFpEF) remains a common condition with no pharmacological treatment. Physical activity (PA) improves symptoms and quality of life (QoL), but no clear recommendations exist on PA in HFpEF patients. We investigated the association of PA (amount/int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobenko, Anna, Bartels, Inke, Münch, Marlene, Trippel, Tobias, Lindhorst, Ruhdja, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Halle, Martin, Duvinage, André, Düngen, Hans‐Dirk, Gelbrich, Götz, Tschöpe, Carsten, Hasenfuss, Gerd, Wachter, Rolf, Pieske, Burkert, Edelmann, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793976/ https://www.ncbi.nlm.nih.gov/pubmed/29210202 http://dx.doi.org/10.1002/ehf2.12227

Ejemplares similares

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study
por: Belyavskiy, Evgeny, et al.
Publicado: (2018)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2010)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

Erratum to: Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2011)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study
por: Gevaert, Andreas B., et al.
Publicado: (2022)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
por: Bahls, Martin, et al.
Publicado: (2019)

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)

Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
por: Hashemi, Djawid, et al.
Publicado: (2020)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study
por: Wachter, Rolf, et al.
Publicado: (2013)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor
por: Zelenak, Christine, et al.
Publicado: (2017)

Peak O(2)‐pulse predicts exercise training‐induced changes in peak V̇O(2) in heart failure with preserved ejection fraction
por: Mueller, Stephan, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure
por: McGranaghan, Peter, et al.
Publicado: (2021)

Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2022)

Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
por: Lechner, Katharina, et al.
Publicado: (2021)

Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study
por: Wachter, Rolf, et al.
Publicado: (2012)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Incremental prognostic value of a novel metabolite‐based biomarker score in congestive heart failure patients
por: McGranaghan, Peter, et al.
Publicado: (2020)

Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure
por: Tanacli, Radu, et al.
Publicado: (2019)

Delayed coronary obstruction after lotus transcatheter aortic valve replacement treated with left main stent in stent implantation
por: Krisper, Maximilian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_la0mt8k8moer0dgv2pii9t3i3q